Skip to content
10-K

Annual Report

CONSTELLATION PHARMACEUTICALS INC

0001564590-20-009735

← back to feed
Filed
Mar 10, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Mar 6, 2020 41.81M sh
Cash And Equivalents FY 2019 · Dec 31, 2018 $114.59M
Current Liabilities FY 2019 · Dec 31, 2018 $14.66M
Total Liabilities FY 2019 · Dec 31, 2018 $14.78M
Current Assets FY 2019 · Dec 31, 2018 $117.3M
Total Assets FY 2019 · Dec 31, 2018 $118.94M
Net Income FY 2019 · Dec 31, 2018 −$19.94M
Net Income FY 2019 · Sep 30, 2018 −$15.94M
Net Income FY 2019 · Jun 30, 2018 −$11.94M
Net Income FY 2019 · Mar 31, 2018 −$12.1M
Net Income FY 2019 · Dec 31, 2017 −$35.38M
Capex FY 2019 · Dec 31, 2017 $582K
Operating Cash Flow FY 2019 · Dec 31, 2017 −$37.59M
Sga Expense FY 2019 · Dec 31, 2017 $6.47M
Rd Expense FY 2019 · Dec 31, 2017 $32.62M
Operating Income FY 2019 · Dec 31, 2017 −$39.09M